Vukičević Slobodan, akademik

Redoviti članovi IV. Razred za medicinske znanosti
Vukičević Slobodan

Datum rođenja:

  • 17.05.1951

Mjesto rođenja:

  • Zagreb

Adrese:

  • Laboratorij za mineralizirana tkiva Centar za translacijska i klinička istraživanja Sveučilište u Zagrebu Medicinski fakultet Šalata 11, 10000 Zagreb

Telefoni:

  • Laboratorij  +385 01 4566 812
  • Telefaks, Laboratorij  +385 01 4566 822
  • Razred za medicinske znanosti HAZU +385 01 4895 171

E-mail adrese:

Vukičević Slobodan, akademik

Redoviti članovi IV. Razred za medicinske znanosti

Akademske titule:

  • akademik
  • profesor doktor znanosti

Institucije:

  • redoviti profesor – Medicinski fakultet Sveučilišta u Zagrebu

Članstvo u Akademiji:

  • redoviti član – Razred za medicinske znanosti (15.05.2014. – …)

Životopis

Slobodan Vukičević redovni je profesor na Zavodu za anatomiju i kliničku anatomiju i voditelj je Laboratorija za mineralizirana tkiva, Centra za translacijska i klinička istraživanja, Medicinskog fakulteta Sveučilišta u Zagrebu, te Hrvatskog znanstvenog centra izvrsnosti za regenerativnu medicinu. Osnivač je Genere istraživanja, prve hrvatske biotehnološke kompanije. Usavršavao se u više inozemnih znanstvenih i edukativnih institucija, kao što su Institut za patologiju, Laboratorij za metabolizam i bolesti kostiju (Sveučilište Heidelberg, Njemačka; 1984 – 1985, stipendist Humboldt fondacije), Nacionalni institut za zdravstvo (National Institute of Health, NIH), Odjel za biologiju koštanih stanica i Laboratorij za razvojnu biologiju i anomalije (Bethesda, SAD; 1988 – 1990, stipendist Fogarty fondacije), NIH, Laboratorij za biologiju koštanih stanica (Bethesda, SAD; 1992 – 1994, suvoditelj), Sveučilište Harvard, Laboratorij za sistemsku biomedicinu (Boston, SAD, 2007, 2008), farmaceutska kompanija Pfizer, Inc. (Groton, SAD, 1997, 2002, 2005, 2006).

Osnovao je Laboratorij za mineralizirana tkiva (1986), koji je danas dio Centra za translacijska i klinička istraživanja u medicini Medicinskog fakulteta Sveučilišta u Zagrebu. Suosnivač je Genere istraživanja, prve hrvatske biotehnološke kompanije (2001), Centra za funkcionalnu genomiku Medicinskog fakulteta Sveučilišta u Zagrebu i KBC Zagreb (2003); Odjela za proteomiku Medicinskog fakulteta Sveučilišta u Zagrebu, KBC Zagreb i Instituta Ruđer Bošković (2007); te Hrvatskog znanstvenog centra izvrsnosti za regenerativnu medicinu (2015-2024).

Objavio je više od 220 znanstvenih radova i poglavlja u knjigama u znanstvenim časopisima visokog faktora odjeka (vidi Bibliografiju) koji su citirani više od 8300 puta, h-indeks 48 (Web of Knowledge), odnosno 12000 puta, h-indeks 54 (Google Scholar). Inventor je na više od 30 globalnih patenata, te urednik četiri knjige o regeneraciji organa koštanim morfogenetskim proteinima (eng.: bone morphogenetic protein, BMP). Član je ocjenjivačkog odbora za EU Framework Programme for Research and Innovation “HORIZON 2020”, u sklopu kojeg je bio predsjedavatelj panela Advandced Grants LS7: Diagnostic tools, therapies and public health Europskog vijeća za znanost (ERC) 2015. i 2017. godine.

Trenutno koordinira suradni H2020 projekt „OSTEOproSPINE – Novel Bone Regeneration Drug “Osteogrow”: Therapeutic Solution for Lumbar Back Pain – (Europska komisija, HORIZON2020 program, 2017 – 2022, 6 mil. €) u sklopu kojeg se provode klinička istraživanja inovativnog, globalnog lijeka „OSTEOGROW“ u bolesnika sa boli u slabinskoj kralježnici i nogama u suradnji s dvanaest partnera iz pet europskih država (Hrvatska, Austrija, Njemačka, Poljska, Slovenija). Otkriće biokompatibilnog nosača za osteogene proteine temeljenog na ugrušku pune krvi dovelo je do kliničkog testiranja novog lijeka za regeneraciju kosti u sklopu upravo uspješno okončanog projekta kliničkog razvoja patentom zaštićenog lijeka za liječenje defekata kosti ”OSTEOGROW” vrijednog 5.683.000 €, financiranog od Europske komisije za znanost (FP7 HEALTH) koja je 2010. godine prvi puta uopće odobrila znanstveno inovativni projekt hrvatskoj instituciji na koordinaciju (Medicinski fakultet Sveučilišta u Zagrebu). Također je koordinator Hrvatskog znanstvenog centra izvrsnosti za reproduktivnu i regenerativnu medicinu (2,5 mil €) u kojem surađuje više hrvatskih znanstvenih instituta, sveučilišta i farmaceutskih kompanija, a koji je financiran iz regionalnih fondova Europske unije za hrvatske centre izvrsnosti; te vodi projekt Hrvatske zaklade za znanost „BMP6Fe3 – Razvoj novih antitijela koja selektivno inhibiraju izražaj hepcidina u jetri“ (2017 – 2020, 133.000,00 €) koji ima potencijal razvoja biološkog lijeka za terapiju anemije kronične bolesti.

Dobio je više nagrada za postignuća u znanosti, uključujući “Ruđer Bošković” nagradu za znanstvena postignuća u biomedicini (1992); „W.D. Wilson“ stipendiju za posjetu vrsnih stručnjaka južnoafričkim sveučilištima – E. Oppenheimer Memorial Trust (1994); “TOSSE” plenarno predavanje, 12. CRHUKS skup, Heidelberg, Njemačka (1996); ˝Anton Šercer˝ nagradu Akademije medicinskih znanosti Hrvatske za rad objavljen u Journal of Clinical Investigation 102:202-214, 1998. (2000); član EMBO (European Molecular Biology Organization), Heidelberg, Njemačka (2000); nagradu za najbolji koautorski rad objavljen u Actra Orthopaedica Scandinavica (2000); nagradu Grada Zagreba za znanost (2001); „Marshall Urist“ plenarno predavanje, 5th International Conference on BMPs, Nagoya, Japan (2003); počasni predsjedatelj 6th International Conference on BMPs, Lake Tahoe, SAD (2008); „Robert Frank“ plenarno predavanje, IADR/PER Congress 2014, Dubrovnik; redovni član Hrvatske akademije znanosti i umjetnosti (HAZU) od 2014. godine; koordinator Hrvatskog znanstvenog centra izvrsnosti za regenerativnu medicinu (2015-2024); predsjedavatelj panela LS7–Diagnostic Tools, Therapies and Public Health, ERC Advanced Grant za 2015. i 2017. godinu; priznanje „Neka zvijezde sjaje“ devet hrvatskih zastupnika Europskog parlamenta timu projekta Osteogrow koji je odabran da predstavlja RH u Europskom parlamentu 2018. godine (2017), nagradu za životno djelo za 2019. godinu za doprinos u području biomedicine i zdravstva.

Više od 200 puta bio je pozvani predavač u poznatim svjetskim znanstvenim ustanovama i sveučilištima i predsjedavatelj na međunarodnim kongresima. Organizirao je više međunarodnih kongresa, uključujući 1. i 2. europski kongres o koštanim morfogenetskim proteinima u Zagrebu 1998. i 2002. godine, 27. kongres European Calcified Tissue Society (ECTS) 2002. godine u Zagrebu; ECTS tečaj 2006. godine u Dubrovniku, 6. međunarodni kongres o koštanim morfogenetskim proteinima 2006. u Dubrovniku, te 13. međunarodni kongres o koštanim morfogenetskim proteinima koji će se održati u Dubrovniku 2021. Bio je član znanstvenog i/ili organizacijskog odbora više međunarodnih znanstvenih kongresa, uključujući 1st  International Conference on BMPs, Baltimore, SAD (1994), 27th European Calcified Tissue Symposium, Tampere, Finska (2000), 3rd International Conference on BMPs, Lake Tahoe, CA, SAD (2000), 4th International Conference on BMPs, Sacramento, CA, SAD (2002), 31st European Symposium on Calcified Tissues, Nica, Francuska (2004), 5th International Conference on BMPs, Nagoya, Japan (2004), 8th International Conference on BMPs, Leuven, Belgija (2010), 10th International Conference on BMPs, Berlin, Njemačka (2014), 11th International Conference on BMPs, Boston, SAD (2016), 12th International Conference on BMPs, Tokyo, Japan (2018).

Predsjednik je Hrvatskog društva za kalcificirana tkiva, te član Svjetske akademije znanosti i umjetnosti (World Academy of Arts and Sciences, WAAS), European Molecular Biology Organization (EMBO), European Calcified Tissue Society (ECTS); American Society of Bone and Mineral Research (ASBMR); American Society for Biochemistry and Molecular Biology (ASBMB); Société Internationale de Chirurgie Orthopédique et de Traumatologie (SICOT); Center for Inquiry Croatia (CFI Croatia); Uredničkog odbora Calcified Tissue International i International Orthopaedics; te International Bone and Mineral Society.

Mentor je 14 magistarskih i 31 doktorske disertacije. Većina znanstvenika koji su educirani u Laboratoriju za mineralizirana tkiva radi u poznatim hrvatskim i inozemnim institucijama, kao što su Cleveland Clinics, SAD (direktor Cleveland fondacije T. Mihaljević), Pfizer Inc, SAD (voditelj toksikoloških studija Č. Bagi), Massachusetts General Hospital, Boston, SAD (nefrolog Petra Šimić), Medicinski fakultet Sveučilišta u Mostaru, Bosna i Hercegovina (akademkinja Lj. Ostojić), Medicinski fakultet Sveučilišta u Rijeci (anatomi I. Marić i S. Zoričić), Medicinski fakultet Sveučilišta u Zagrebu (otorinolaringolog V. Katić; plastični kirurg R. Žic; hematolog N. Lang; anatom A. Marušić; predstojnica Kliničkog zavoda za laboratorijsku dijagnostiku D. Rogić; nefrolog N. Bašić; neurolog V. Bašić; bivši ravnatelj KBC Zagreb endokrinolog Z. Giljević; ortopedi N. Čičak i M. Jelić; forenzičar M. Kubat; voditelj Centra za translacijska i klinička istraživanja F. Borovečki; voditelj Odjela za proteomiku L. Grgurević; plastični kirurg K. Bulić; otorinolaringolog M. Grgić; onkolog M. Pastorčić, predstojnik Klinike za unutarnje bolesti KB Dubrava I. Grgurević; znanstvenici J. Brkljačić, I. Erjavec, V. Kufner, M. Pauk); Klinika za traumatologiju, KBC Sestre Milosrdnice (traumatolog D. Đurđević), i drugi.

Njegovi znanstveni interesi uključuju molekularne mehanizme koštanog cijeljenja; otkriće koštanih i hrskavičnih morfogenih proteina; mehanizme prijenosa signala u osteoblastima i stanicama bubrega; biološku regeneraciju tkiva s posebnim osvrtom na kost, hrskavicu, bubreg i pankreas; osmišljavanje i vođenje kliničkih studija o metaboličkim bolestima kosti i regeneraciji zglobne hrskavice. Kao posljedica dugogodišnjeg istraživanja cijeljenja kosti i usavršavanja u postupcima razvoja novog lijeka sa suradnicima je otkrio novi lijek za regeneraciju kosti koji se trenutačno testira u kliničkim istraživanjima u Zagrebu, Beču, Linzu i Gracu u tri indikacije (cijeljenje palčane kosti, visoka osteotomija tibije i posterolateralna fuzija slabinskih kralježaka). To je prvi puta uopće da je konzorcij akademskih institucija uspio razviti lijek, GMP (eng. good manufacturing practice) proizvodnju lijeka, dobiti sve regulatorne dozvole u Europskoj uniji i provesti kliničko testiranje bez licenciranja prava farmaceutskoj industriji. U slučaju pozitivnog ishoda Hrvatska će postati deseta država u svijetu koja može samostalno razviti i klinički testirati originalni inovativni biološki lijek.

Voditelj i koordinator projekata

  1. „Reproduktivna i regenerativna medicina – istraživanja novih platformi i potencijala (KK.01.1.1.01.0008)“ u sklopu Hrvatskog znanstvenog centra izvrsnosti za regenerativnu medicinu, 2017-2022 (EU iz Europskog fonda za regionalni razvoj) [37.999.993,39 kn (37.569.493,39 kn financira EU)]
  2. „OSTEOproSPINE: Novel Bone Regeneration Drug “Osteogrow”: Therapeutic Solution for Lumbar Back Pain“ 2017-2022 (Europska komisija, HORIZON 2020 program, br. ugovora 779340) [6.000.000,00 €]
  3. „BMP6Fe3 – Razvoj novih antitijela (biološki lijek) koja selektivno inhibiraju izražaj hepcidina u jetri za terapiju anemije kronične bolesti“ 2017 – 2020 (Hrvatska zaklada za znanost) [133.000,00 €]
  4. „Hrvatski znanstveni centar izvrsnosti za regenerativnu medicinu“ 2015 – 2024 (EU regionalni fond za centre izvrsnosti) [4.200.000,00 €]
  5. “OSTEOGROW – Novel Bone Morphogenetic Protein 6 Biocompatible Carrier Device for Bone Regeneration” 2012 – 2017 (Europska komisija, FP7 HEALTH program, br. ugovora 279239) [5.683.000,00 €]
  6. “Nova ciljana anabolička terapija za liječenje osteoporoze: BONE6-BIS konzorcij” 2012 – 2014 (Hrvatska zaklada za znanost) [195.000,00 €]
  7. “Novi intervencijski postupak uvođenjem tehnologije poboljšanja srčane funkcije nakon preboljenog infarkta miokarda” 2012 -2013 (BICRO PoC 4 projekt) [25.000,00 €]
  8. UKF program znanstvene suradnje – „preko granice“ „Bone morphogenetic protein 1 isoforms in bone regeneration“ 2010-2012 (Ministarstvo znanosti, obrazovanja i športa i UKF) [180.000,00 €]
  9. “Uloga TSH u modelu osteoporoze i u bolesnica sa smanjenom koštanom masom“ 2007 (Ministarstvo znanosti, obrazovanja i športa) [195.000,00 €]
  10. “BMP u razvoju bubrega” (NIH grant, zajednički američko-hrvatski znanstveni odbor)
  11. “Uloga TSH u regeneraciji kosti” 2005 (Genzyme Corp., SAD – Medicinski fakultet, Sveučilište u Zagrebu) [40.000,00 €]
  12. TEST projekt “Osteoinduktivna molekula” 2004-2006 (Ministarstvo znanosti, obrazovanja i športa, Institut za tehnologiju) [90.000,0 €]
  13. “Učinkovitost i mehanizmi djelovanja BMP-6 u liječenju osteoporoze ” 2002-2006 (Ministarstvo znanosti, obrazovanja i športa)  [120.000,00 €]
  14. “Mehanizmi djelovanja prostaglandina u formaciji kosti” 2002-2004 (Pfizer Inc., SAD – Medicinski fakultet, Sveučilište u Zagrebu) [90.00,00 €]
  15. “Oralna primjena BMP za sistemsko povećanje kosti” 1999-2003 (PLIVA-Medicinski fakultet, Sveučilište u Zagrebu) [700.000,00 €]
  16. “Regeneracija hrskavice uporabom BMP-7” 1997-2000 (Stryker Biotech, SAD – Medicinski fakultet, Sveučilište u Zagrebu) [170.000,00 €]
  17. “BMP-7 (OP-1) u zaštiti i liječenju bolesti bubrega” 1996-2002 (Ministarstvo znanosti, obrazovanja i športa) [120.000,00 €]
  18. “Uloga ekstracelularnog matriksa u morfogenezi hrskavice i kosti“ 1990-1995 (Ministarstvo znanosti, obrazovanja i športa) [60.000,00 €]

Odobreni patenti

  1. Sampath KT, Cohen CM, Vukicevic S. Therapies for acute renal failure (CA 2289123, issue date Nov 12, 1998)
  2. Sampath KT, Cohen CM, Vukicevic S. Morphogen treatment for chronic renal failure (EP0914146, issue date Sep 29, 2004)
  3. Cohen CM, Sampath KT, Vukicevic S. Therapies for chronic renal failure (US 6861404, issue date Mar 1, 2005)
  4. Vukicevic S, Katic V,  Sampath KT. Use of OP1 for the preparation of a pharmaceutical composition or repairing a defect locus in a non-articular cartilage tissue of a mammal (EP1117422, issue date Sep 28, 2005)
  5. Vukicevic S, Katic V, Sampath KT. Repair of larynx, trachea, and other fibrocartilaginous tissues (US 6958149, issue date Oct 25, 2005)
  6. Cohen CM, Sampath KT, Vukicevic S. Therapies for chronic renal failure (US 7524817, issue date Apr 28.2009)
  7. Vukicevic S, Katic V, Sampath KT. Method for repairing a defect in an intervertebral disc (US 7572440, issue date Aug 11, 2009)
  8. Vukicevic S, Simic P. Insulin-independent, bone morphogenetic protein (BMP)-mediated uptake of blood glucose by peripheral cells and tissues (AU-2005251741, issue date Sep 24, 2009)
  9. Vukicevic S, Katic V, Sampath KT. Devices and method for repair of larynx, trachea, and other fibrocartilaginous tissues (US 7803369, issue date Sep 28, 2010)
  10. Vukicevic S, Grgurevic L, Macek B. BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders (US 7850964, issue date Dec 14, 2010)
  11. Cohen CM, Sampath KT, Vukicevic S. Therapies for chronic renal failure (US 8017580, issue date Sep 13, 2011)
  12. Vukicevic S, Katic V, Sampath KT. Method for repairing a defect in an intervertebral disc (US RE42954, issue date Nov 22, 2011)
  13. Vukicevic S, Jelic M. Methods and compositions for regenerating articular cartilage (AU 2006275444, issue date Feb 10, 2011)
  14. Vukicevic S, Jelic M. Methods and compositions for regenerating articular cartilage (US 8119591, issue date Feb 21, 2012) (PCT/US2006/030077; WO 2007/016620)
  15. Vukicevic S, Grgurevic L. ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure (EP 2171450, issue date Mar 21, 2012)
  16. Grgurevic L, Macek B, Vukicevic S. Blood biomarkers for bone fracture and cartilage injury (US 8182998, issue date May 22, 2012)
  17. Vukicevic S, Grgurevic L, Oppermann H. Whole blood-derived coagulum device for treating bone defects (US 8197840, issue date Jun 12, 2012) (PCT/US2007/016601; WO 2008/011192)
  18. Vukicevic S, Katic V, Sampath KT. GDF-5 for use in repairing a nonarticular cartilage defect in an intervertebral disc (EP1649865, issue date Jun 13, 2012)
  19. Vukicevic S, Grgurevic L, Macek B. BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders (JP 5016041, issue date Jun 15, 2012)
  20. Vukicevic S, Grgurevic L, Macek B. BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders (AU 2007275580, issue date Jul 12, 2012)
  21. Vukicevic S, Grgurevic L, Oppermann H. Whole blood-derived coagulum device for treating bone defects (AU 2007275579, issue date Aug 16, 2012)
  22. Grgurevic L, Vukicevic S. ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure (US 8263072, issue date Sep 11, 2012) (PCT/US2008/007713; WO 2009/002451)
  23. Vukicevic S, Grgurevic L, Macek B. BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders (EP2518496, issue date Oct 31, 2012)
  24. Vukicevic S, Simic P. Insulin-independent, bone morphogenetic protein (BMP)-mediated uptake of blood glucose by peripheral cells and tissues (CA 2568305, issue date May 28, 2013)
  25. Vukicevic S, Jelic M. Methods and compositions for regenerating articular cartilage (CA 2617578, issue date Dec 17, 2013)
  26. Vukicevic S, Grgurevic L, Macek S. BMP1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders (CA 2658582, issue date Dec 10, 2013)
  27. Vukicevic S, Grgurevic L, Oppermann H. Dispositif a coagulum derive du sang total pour le traitement de defauts osseaux (Whole blood-derived coagulum device for treating bone defects) (CA 2657819, issue date May 20, 2014)
  28. Vukicevic S, Grgurevic L, Macek B. Methods of preventing ischemia/reperfusion damage to kidney using antibodies that bind BMP-1 isoforms (US 8765127; issue date Jul 1, 2014)
  29. Vukicevic S, Jelic M. Methods and compositions for regenerating articular cartilage (US 8796208, issue date Aug 5, 2014)
  30.  Vukicevic S, Grgurevic L, Macek B. BMP-1 Procollagen C-Proteinase for Diagnosis and Treatment of Bone and Soft Tissue Defects and Disorders (JP 5616921, issue date Sep 19, 2014)
  31. Vukicevic S, Grgurevic L, Oppermann H. Whole blood-derived coagulum device for treating bone defects (EP2049040, issue date Apr 1, 2015; AT E718684T1, validated in Austria Apr 28, 2017)
  32. Vukicevic S, Grgurevic L, Macek B. BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders (AU 2012200193, issue date Jul 23, 2015)
  33. Vukicevic S, Grgurevic L, Oppermann H. Whole blood-derived coagulum device for treating bone defects (Turkish Patent No. 2015/08147, issue date Jul 1, 2015)
  34. Vukicevic S, Grgurevic L, Macek B. Anti-BMP-1-1 and anti-BMP-1-3 antibodies for use in the treatment of chronic renal failure. (EP 2049893, issue date Nov 30, 2016)
  35. Vukicevic S, Grgurevic L, Dumic-Cule I. BMP1 Methods and compositions for treating and diagnosing acute myocardial infarction (JP 6133402, issue date May 24, 2017)
  36. Vukicevic S, Grgurevic L, Macek B. BMP-1 Procollagen C-Proteinase for Diagnosis and Treatment of Bone and Soft Tissue Defects and Disorder (JP 6152154, issue date Jul 2, 2017) 406.1 JP-3
  37. Vukicevic S, Grgurevic L, Dumic-Cule I. Methods and compositions for treating and diagnosing acute myocardial infarction. (New Zealand Patent No. 631639, issue date Jan 5, 2017)
  38. Vukicevic S, Sampath KT, Grgurevic L, Cohen C, Oppermann H. Autologous bone graft substitute composition useful e.g. for inducing new bone formation and promoting bone growth, comprises autologous blood, osteogenic bone morphogenetic protein, compression resistant matrix and blood clotting agent (EP WO2019076484-A1, publication date Apr 25, 2019)
  39. Jelic M, Vukicevic S. External load bearing distracting device for articulating anatomical joint, has two retaining components and units that are enabling, adjusting and fixing first component and third component at desired longitudinal position. (EP WO2019007550-A1, publication date Jan 10, 2019)

Bibliografija

  1. Vukicevic S, Hancevic J, Vukicevic D. Use of holographic interferometry in the biomechanics of the osseous system. Liječnički Vjesnik 97:16-21, 1975.
  2. Vukicevic D, Hancevic J, Nikolic V, Vukicevic S. Application of holographic interferometry in the biomechanics of the locomotor system. Conference on Electrocochleography and Holography in Medicine, Munster, FRG, 1976, 113-120.
  3. Hudec M, Hancevic J, Schellman W.D, Hudec F, Nikolic V, Banovic B, Vukicevic S. Uber das mechanische Zusammenwirken von Implataten und Knochen nach Verschiedenen Osteosynthesenverfahren. Hefte Unfallheilkunde 129:21-26, 1977.
  4. Hancevic J, Nikolic V, Hudec M, Vukicevic S, Vinter I. Use of polymethylacrylate (Palacos) in the treatment of the proximal part of the knee bone (experimental work)]. Acta Chirurgica Iug 2:225-230, 1977.
  5. Vukicevic S, Vukicevic D, Nikolic V, Hancevic J. Biomechanical analysis of the ankle joint by holographic interferometry. Acta Medica Iugoslavica 31:251-259, 1977.
  6. Nikolic V, Hudec M, Hancevic J, Banovic B, Vukicevic S. Anatomical specimen: as a reliable model for biomechanical investigations of the locomotor system. In: Mechanics of biological solids (ED. G. Brankov), Varna, Bulgarian Academy of Sciences, 1977, 188-210.
  7. Nikolic V, Vukicevic D, Vukicevic S, Rajic Z, Hancevic J. Biomechanical investigations of the human supportive system by holographic interferometry. Elektrotehnika 4:330-337, 1977.
  8. Vukicevic D, Nikolic V, Vukicevic S, Hancevic J, Sucur Z. Holographic investigations of mechanical characteristics of the complex leg-foot in conditions of lesion and reconstruction. In: Holography in Medicine and Biology (Ed. G. von Bally), Springer Series in Optical Sciences, Springer Verlag, Berlin, Heidelberg, New York, Vol. 18, 1979, 34-48.
  9. Nikolic V, Sajko D, Vukicevic S, Hancevic J, Vikic S, Vinter I. Photodensitometric evaluation of bone fracture repair (Ed. G. Mazes), National Institutes of Health Publication 18:1830-1842, 1980 (Abstract: American Journal of Roentgenology 131;533, 1978).
  10. Vukicevic S, Stern-Padovan R, Vinter I. The influence of intermittent loading on osteocyte morphology. Collegium Antropologicum (Suppl) 4:99-103, 1980.
  11. Stern-Padovan R, Vukicevic S. Histologic changes in the ageing spiral tract. Journal of Laryngology and Otology 94:255-262, 1980. (IF 0.851; Q3/OTORHINOLARYNGOLOGY)
  12. Vinter I, Vukicevic S, Stern-Padovan R. Planimetric analysis of bone remodeling in the rat. Collegium Antropologicum (Suppl.) 4:83-87, 1980.
  13. Vinter I, Vukicevic S, Stern-Padovan R. The influence of intermittent mechanical loading on the remodeling of the nutritive chanel in the diaphysis of femur and tibiofibular junction of rats. Folia Anatomica 1:59-63, 1980.
  14. Vukicevic S, Stern-Padovan R, Vukicevic D, Keros P. Holographic investigations of the human tibiofibular interosseous membrane. Clinical Orthopedics and Related Research 151:210-214, 1980. (IF 2.065; Q1/ORTHOPEDICS)
  15. Vukicevic S, Stern-Padovan R, Vukicevic D, Hancevic J. Further contribution to the function of the tibiofibular unit. Collegium Antropologicum 2:201-205, 1980.
  16. Vukicevic S, Pavlin D, Vukicevic D, Stern-Padovan R, Skrinjaric I. Recent advances in holographic investigations of the human skeleton: Holography in anatomy and orthopedics. Collegium Antropologicum (Suppl.) 4:87-91, 1980.
  17. Vukicevic S, Vinter I, Stern-Padovan R. A simple technique for undecalcified bone sectioning. Collegium Antropologicum (Suppl.) 5:139-143, 1981.
  18. Vukicevic S, Prejac M, Nikolic V, Antos M, Stern-Padovan R. Undecalcified bone processing in cases of renal osteodystrophy. Proceedings of second Prague symposium on chronic renal failure, Gambre AB, 162-170, 1981.
  19. Vukicevic D, Vukicevic S, Vinter I, Sankovic K. Holographic investigations of the human pelvis. In: Optics in Biomedicine (Eds. G. von Bally and P. Greguss), Springer Series in Optical Sciences, Springer Verlag, Berlin, Heidelberg, New York, 31:144-151, 1982.
  20. Vukicevic S, Plitz W, Vukicevic D, Vinter I, Bergman M. A holographic study of the stresses in the normal pelvis with particular reference to the movement of the sacrum. In: Biomechanics: Principles and Application (Eds. R. Huiskes, et al), Martinus Nijhoff Publ, Hague, Boston, London, Vol. 1, 1982, 113-119.
  21. Vukicevic S, Pecina M, Vukicevic D. “Biomechanics of the knee joint. In: The knee-applied biomechanics (Ed. M. Pecina), JUMENA, Zagreb, 17-33, 1982.
  22. Vukicevic S, Vinter I, Vukicevic D. Application of sandwich holography for determination of gross movements in biomechanics of the human pelvis. Proceedings SPIE 370:129-132, 1983.
  23. Vukicevic S, Stavljenic A, Bagi C, Vujcic G, Kracun I, Vinter I. 1a,25-Dihydroxyvitamin D3 stimulates alkaline phosphatase activity and inhibits soft-tissue proliferation in implants of bone matrix. Clinical Orthopedics and Related Research 196:285-291, 1985. (IF 2.065; Q1/ORTHOPEDICS)
  24. Vukicevic S, Krempien B, Bagi C, Stavljenic A. 1,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 are both necessary for bone composition of intramuscular implants of demineralized bone matrix in rats. In: Vitamin D: Chemical, Biomechanical and Clinical Update, Walter de Gruyter Vol. 6, Berlin, New York, 294-295, 1985.
  25. Katic V, Vukicevic S, Vujicic G, Ivankovic D. Structurelle and Elemente in den Spuren des Schlafenbeins. In: Actuelles in der Otorinolarigologie (Eds. E.H. Mayer, M. Zrunek), Georg Thieme Verlag, New York, 1985, 326-331.
  26. Vukicevic S, Bagi C, Vujicic G, Krempien B, Stavljenic A, Herak M. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat. Bone and Mineral 1:383-396, 1986. ([incorporated into Bone] IF 4.089; Q2/ENDOCRINOLOGY & METABOLISM)
  27. Katic V, Vukicevic S, Vujicic G, Ivankovic D. Different mineral content of auditory ossicles as determined by inductively coupled plasma argon emission spectrometry (ICP-AES). In: Aktuelles in der Otorinolaringologie (Eds. E.H. Majer and M. Zrunek), Georg Thiem Verlag, Stuttgart, New York, 308-311, 1986.
  28. Vukicevic S, Krempien B, Stavljenic A. Effects of 1a,25-and 24R,25-Dihydroxyvitamin D on aluminum induced rickets in growing uremic rats. Journal of Bone and Mineral Research 2:533-545, 1987. (IF 6.043; Q1/ENDOCRINOLOGY & METABOLISM)
  29. Vukicevic S, Marusic A, Stavljenic A, Krempien B. Mechanisms of talc granulomatosis-induced bone loss in the rat. In: Osteoporosis (Eds. C. Christiansen et al), Norhaven AV, Viborg, 1987, 812-814.
  30. Vukicevic S. Aluminum bone disease in children: Radiographic features from diagnosis to resolution. Radiology 163:583 E, 1987 (Letter to the Editor). (IF 6.341; Q1/RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING)
  31. Vukicevic S, Marusic A, Stavljenic A, Cicak N, Vogel M, Krempien B. Talc granulomatosis in the rat: The relationship between osteoblast insufficiency and adjacent bone-marrow hyperplasia. Experimental Haematology 16:735-740, 1988. (IF 3.106; Q2/HEMATOLOGY)
  32. Vujicic G, Vukicevic S, Steiner JD, Siroki M, Stavljenic A, Herak M. Method for determination of carbonate by the induction of CO2 into an inductively coupled plasma. Spectrochimica Acta Part B-atomic Spectroscopy 43 B:867-872, 1988. (IF 2.719; Q1/SPECTROSCOPY)
  33. Radic I, Vucak I, Milosevic J, Marusic A, Vukicevic S, Marusic M. Immunosuppression induced by talc-granulomatosis in the rat. Clinical and Experimental Immunology 73:316-321, 1988. (IF 3.009; Q2/IMMUNOLOGY)
  34. Krempien B, Vukicevic S, Vogel M, Stavljenic A, Buchele R. Cellular basis of inflammation-induced osteopenia in growing rats. Journal of Bone and Mineral Research 3:573-582, 1988. (IF 6.043; Q1/ENDOCRINOLOGY & METABOLISM)
  35. Vukicevic S, Stavljenic A, Bradamante Z. The evaluation of the structure and metabolism of connective and osseous tissues, In: Patophysiology (Eds. S. Gamulin, M. Marusic and S. Krvavica), JUMENA, Zagreb, 1988, 733-758 (Major textbook).
  36. Vukicevic S, Bagi C. Metabolic bone diseases, In: Patophysiology (Eds. S. Gamulin et al.), JUMENA, Zagreb, 1988, 741-753 (Major textbook).
  37. Vukicevic S, Marusic A. Alterations of the calcium, phosporus and magnesium metabolism. In: Patophysiology (Eds. S. Gamulin et al), JUMENA, Zagreb, 1988, 271-290.
  38. Stavljenic A, Vukicevic S. Determination of trace elements. In: Patophysiology (Eds. S. Gamulin et al), JUMENA, Zagreb, 1988, 235-238.
  39. Vukicevic S, Pintaric I, Marusic A, Zic R. Subcutaneous Walker-256 carcinosarcoma in the rat: Dynamics of the bone cells and the etiology of hypercalcemia. Radovi Medicinskog Fakulteta 28:47-52, 1988.
  40. Vukicevic S, Stavljenic A. Aluminum accumulates on inactive bone surfaces after late parathyroidectomy in uremic rats. Hormone and Metabolic Research 21:15-17, 1989. (IF 2.686; Q2/ENDOCRINOLOGY & METABOLISM)
  41. Vukicevic S, Kracun I, Stavljenic A, Kelovic Z, Krempien B, Rösner H. The effects of aluminum on brain gangliosides in uremic rats treated with 24R,25-Dihydroxyvitamin D. Neuropathology and Applied Neurobiology 15:55-62, 1989. (IF 3.495; Q1/CLINICAL NEUROLOGY)
  42. Vukicevic S, Marusic A, Stavljenic A, Vinter I, Rudez V. New bone formation in the autologous membranous bone transplanted into anterior abdominal wall. Plastic and Reconstructive Surgery 83:889-891, 1989. (IF 2.743; Q1/SURGERY)
  43. Vukicevic S, Stavljenic A, Boll Th, Cervar M, Degenhardt Ch, Mihaljevic T and Krempien B. The influence of early parathyroidectomy on aluminum-induced rickets in growing uremic rats. Bone and Mineral 6:125-139, 1989. ([incorporated into Bone] IF 4.089; Q2/ENDOCRINOLOGY & METABOLISM)
  44. Vukicevic S, Stavljenic A, Boll Th, Cervar M, Degenhardt Ch, Krempien B. The effects of aluminum loading on selected tissue calcium, phosphorus, magnesium and copper concentrations in uremic rats. Biological Trace Elements Research 22:45-53, 1989. (IF 1.127; Q4/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  45. Vukicevic S, Luyten FP, Reddi AH. Stimulation of the expression of osteogenic and chondrogenic phenotype in vitro by osteogenin. Proceedings of the National Academy of Sciences of the USA 86:8793-8797, 1989. (IF 9.432; Q1/MULTIDISCIPLINARY SCIENCES)
  46. Cervar M, Stavljenic A, Vukicevic S. Aluminum intoxication. Lijecnicki Vjesnik 111:164-169, 1989.
  47. Marusic A, Kos K, Stavljenic A, Vukicevic S. Talc-granulomatosis in the rat: involvement of bone in the acute-phase response. Inflammation 14:206-216, 1990. (IF 1.642; Q4/CELL BIOLOGY)
  48. Vukicevic S, Luyten FP, Reddi AH. Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cells (MC3T3-E1). Biochemical and Biophysical Research Communication 166:750-756, 1990. (IF 2.548; Q3/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  49. Vukicevic S, Paralkar V, Cunningham N, Gutkind S, Reddi AH. Autoradiographic localization of osteogenin binding sites in cartilage and bone during rat embryonic development. Developmental Biology 140:209-214, 1990. (IF 4.379; Q1/DEVELOPMENTAL BIOLOGY)
  50. Vukicevic S, Luyten FP, Kleinman HK, Reddi AH. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: Regulation by discrete domains of laminin. Cell 63:437-445, 1990. (presented on cover) (IF 31.152; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  51. Paralkar VM, Vukicevic S, Reddi AH. Transforming growth factor B type 1 binds to collagen type IV of basement membrane matrix: Implications for development. Developmental Biology 143:303-308, 1991. (IF 4.379; Q1/DEVELOPMENTAL BIOLOGY)
  52. Vukicevic S, Marusic A, Stavljenic. A, Vujicic G, Skavic J, Vukicevic D. Holographic analysis of the human pelvis. Spine 16:209-214, 1991. (IF 2.624; Q1/ORTHOPEDICS)
  53. Marusic A, Kos K, Stavljenic A, Vukicevic S. Acute zinc deficiency and trabecular bone loss in rats with talc granulomatosis. Biological Trace Elements Research 29:165-173, 1991. (IF 1.127; Q4/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  54. Cesnjaj M, Stavljenic A, Vukicevic S. In vivo models in the study of osteopenias. European Journal of Clinical Chemistry and Clinical Biochemistry 29:211-219, 1991. (IF 1.886; Q2/MEDICAL LABORATORY TECHNOLOGY)
  55. Katic V, Vujicic G, Ivankovic D, Stavljenic A, Vukicevic S. Structural and trace element distribution in auditory ossicles measured by inductively coupled plasma argon emission spectrometry. Biological Trace Elements Research 29:35-43, 1991. (IF 1.127; Q4/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  56. Cesnjaj M, Stavljenic A, Vukicevic S. Decreased osteoinductive potential of bone matrix from ovariectomized rats. Acta Orthopedica Scandinavica 62:471-475, 1991. (IF 1.909; Q2/ORTHOPEDICS)
  57. Luyten FP, Yu YM, Yanagishita M, Vukicevic S, Hammonds G, Reddi AH. Native bovine osteogenin and recombinant human bone morphogenetic protein 2B are equipotent in the maintenance of the steady-state of proteoglycans in bovine articular cartilage explants. Journal of Biological Chemistry 267:3691-3695, 1992. (IF 5.328; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  58. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Experimental Cell Research 202:1-8, 1992. (IF 3.589; Q2/CELL BIOLOGY i ONCOLOGY)
  59. Vukicevic S, Somogyi L, Martinovic I, Zic R, Kleinman HK, Marusic M. Reconstituted basement membrane (Matrigel) influences the survival and growth of murine tumors. International Journal of Cancer 50:791-795, 1992. (IF 4.722; Q1/ONCOLOGY)
  60. Luyten FP, Cunningham NS, Vukicevic S, Paralkar V, Ma S, Ripamonti U, Reddi AH. Role of osteogenin and related bone morphogenetic proteins in bone induction and repair. Acta Orthopedica Belgica 58:263-267, 1992. (IF 0.403; Q4/ORTHOPEDICS)
  61. Vukicevic S. Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. Bone 13:119, 1992 (Letter to the Editor) (IF 4.089; Q2/ENDOCRINOLOGY & METABOLISM)
  62. Vukicevic S, Kracun I, Vukelic Z, Krempien B, Rösner H, Cosovic C. 24R, 25-Dihydroxyvitamin D3 prevents aluminum-induced alteration of brain gangliosides in uremic rats by keeping the metal within perivascular astrocytes of the blood-brain barrier. Neurochemistry International 20:391-399, 1992. (IF 3.541; Q2/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  63. Marusic A, Dikic I, Vukicevic S, Marusic M. New bone formation induced by demineralized bone matrix in immunosuppressed rats. Experientia 48:783-785, 1992.
  64. Vukicevic S, Paralkar V, Reddi AH. Extracellular matrix and bone morphogenetic proteins in cartilage and bone development and repair. Advances in Molecular and Cell Biology 7:207-224, 1993.
  65. Marusic A, Kos K, Stavljenic A, Vukicevic S. Role of 1,25-dihydroxyvitamin D3 in the generation of the acute-phase response in rats with talc-induced granulomatosis. Experientia 49:693-698, 1993.
  66. Chen P, Vukicevic S, Sampath TK, Luyten FP. Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of osteogenic protein-1, Biochemical Biophysical Research Communication 197:1253-1259, 1993. (IF 2.548; Q3/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  67. Dieudonne SC, Semeins CM, Goei SW, Vukicevic S, Sampath TK, Helder M, Burger EH. Opposite effects of transforming growth factor beta and Osteogenic protein-1 (OP-1) on chondrogenesis in cultured long bone rudiments. Journal of Bone and Mineral Research 9:771-780, 1994. (IF 6.043; Q1/ENDOCRINOLOGY & METABOLISM)
  68. Stojilkovic SS, Vukicevic S, Luyten FP. Calcium signaling in endothelin- and platelet-derived growth factor-stimulated chondrocytes. Journal of Bone and Mineral Research 9:705-714, 1994. (IF 6.043; Q1/ENDOCRINOLOGY & METABOLISM)
  69. Vukicevic S, Marusic A, Stavljenic A, Cesnjaj M, Ivankovic D. The role of tumor necrosis factor-alpha in the generation of acute phase response and bone loss in rats with talc-granulomatosis. Laboratory Investigation 70:386-391, 1994. (IF 4.602; Q1/MEDICINE, RESEARCH & EXPERIMENTAL)
  70. Vukicevic S, Latin V, Chen P, Batorsky R, Reddi AH, Sampath TK. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: High affinity binding to basement membranes. Biochemical Biophysical Research Communication 198:693-700, 1994. (IF 2.548; Q3/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  71. Vukicevic S, Helder MN, Luyten FP. The developing human lung is a major site of synthesis of bone morphogenetic protein-3 (Osteogenin). Journal of Histochemistry and Cytochemistry 42:869-875, 1994. (IF 2.372; Q3/CELL BIOLOGY)
  72. Somogyi L, Lasic Z, Vukicevic S, Banfic H. Collagen type IV stimulates an increase in intracellular Ca in pancreatic acinar cells via activation of phospholipase C. Biochemical Journal 299:603-611, 1994. (IF 5.155; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  73. Chang SC, Hoang B, Thomas TJ, Vukicevic S, Luyten FP, Ryba NJP, Kozak CA, Reddi AH, Moos M. Cartilage derived morphogenetic proteins, New members of the TGF-beta superfamily predominantly expressed in long bones during human embryonic development. Journal of Biological Chemistry 269:28227-28234, 1994. (IF 5.328; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  74. Basic N, Bulic K, Basic V, Martinovic S, Vukicevic S. Osteogenesis and haemopoiesis: A symbiotic microenvironment. Biochemica Medica 4:101-111, 1994.
  75. Chen P, Vukicevic S, Sampath TK, Luyten FP. Osteogenic protein-1 promotes growth and initiates maturation of chick sternal chondrocytes in serum-free cultures. Journal of Cell Science 108:105-114, 1995. (IF 6.144; Q1/CELL BIOLOGY)
  76. Helder MN, Özkaynak E, Sampath TK, Luyten FP, Oppermann H, Vukicevic S. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. Journal of Histochemistry and Cytochemistry 43:1035-1044, 1995. (IF 2.372; Q3/CELL BIOLOGY)
  77. Vukicevic S, Stavljenic A, Pecina M. Discovery and Clinical applications of bone morphogenetic proteins. European Journal of Clinical Chemistry and Clinical Biochemistry 33:661-671, 1995. (IF 1.886; Q2/MEDICAL LABORATORY TECHNOLOGY)
  78. Ripamonti U, Vukicevic S. Bone morphogenetic proteins: from developmental biology to molecular therapeutics (Editorial). South African Journal of Science 91:277-280, 1995 (presented on cover). (IF 0.506; Q3/MULTIDISCIPLINARY SCIENCES)
  79. Vukicevic S, Latin V, Grgacic S, Sampath TK. Osteogenic protein-1 has a specific localization pattern during human embryonic development. In: Fetus as a patient (Eds. Kurjak A, Latin V, Rippmann E.). CIC Internazionali, Rome, 281-288, 1995.
  80. Martinovic S, Latin V, Suchanek E, Stavljenic A, Sampath TK, Vukicevic S. Osteogenic protein-1 is synthesized by human placental trophoblasts and inhibits secretion of BhCG and progesteron by trophoblasts in vitro. European Journal of Clinical Chemistry and Clinical Biochemistry 34:103-109, 1996. (IF 1.886; Q2/MEDICAL LABORATORY TECHNOLOGY)
  81. Basic N, Basic V, Bulic K, Grgic M, Kleinman AH, Luyten FP, Vukicevic S. TGF-ß and basement membrane Matrigel stimulate the chondrogenic phenotype in osteoblastic cell cultures. Journal of Bone and Mineral Research 11:384-391, 1996. (IF 6.043; Q1/ENDOCRINOLOGY & METABOLISM)
  82. Vukicevic S, Kopp J.B, Luyten, FP, Sampath TK. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proceedings of the National Academy of Sciences of the USA 93:9021-9026, 1996. (IF 9.432; Q1/MULTIDISCIPLINARY SCIENCES)
  83. Hoang B, Moos M, Vukicevic S, Luyten FP. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. Journal of Biological Chemistry 271:26131-26137, 1996. (IF 5.328; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  84. Grgacic S, Suchanek E, Vukicevic S, Latin V. Effects of pulse Doppler ultrasound on placental hormones excretion in vitro. Acta Medica Croatica 50:15-19, 1996.
  85. Özkaynak E, Jin D.F, Jelic M, Vukicevic S, Oppermann H. Osteogenic protein-1 mRNA in the uterine endometrium. Biochemical Biophysical Research Communications 234:242-246, 1997. (IF 2.548; Q3/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  86. Grgić M, Jelić M, Basic V, Basic N, Pecina M, Vukicevic S. Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic protein-7). Acta Medica Croatica 51:23-27, 1997.
  87. Karg H, Helder M.N, Luo G, Karsenty G, Bervoets T.J.M, Vukicevic S, Burger E.H, D’Souza R.N, Woltgens J.H.M, Bronckers ALJJ. Bone morphogenetic protein-7 (Osteogenic protein-1, OP-1) and tooth development. Journal of Dental Research, 77:545-554, 1998. (IF 3.458; Q1/DENTISTRY, ORAL SURGERY & MEDICINE)
  88. Paralkar VM, Vali AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA, Thompson DD. Cloning and characterization of a novel member of the transforming growth factor-beta/ bone morphogenetic protein family. Journal of Biological Chemistry 273:13760-13767, 1998. (IF 5.328; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  89. Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. Journal of Clinical Investigation 102:202-214, 1998. (IF 15.387; Q1/MEDICINE, RESEARCH & EXPERIMENTAL)
  90. Vukicevic S, Martinovic S, Basic M, Jelic M. Bone Morphogenetic Proteins: First European Conference, Zagreb, Croatia, October 7-11, 1998, (Editorial), Bone 24:395-397, 1999. (IF 4.089; Q2/ENDOCRINOLOGY & METABOLISM)
  91. Katic V, Majstorovic L, Maticic D, Pirkic B, Yin S, Kos J, Martinovic S, McCartney JE, Vukicevic S. Biological repair of thyroid cartilage defects by osteogenic protein-1 (bone morphogenetic protein-7) in dog. Growth Factors 17:221-234, 2000. (IF 2.468; Q3/CELL BIOLOGY)
  92. Bosukonda D, Shih MS, Sampath TK and Vukicevic S. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys. Kidney International 58:1902-1911, 2000. (IF 6.193; Q1/UROLOGY & NEPHROLOGY)
  93. Aspenberg A, Basic N, Tagil M, Vukicevic S. Reduced expression of BMP-3 due to mechanical loading – A link between mechanical stimuli and tissue differentiation. Acta Orthopedica Scandinavica 71:558-562, 2000. (IF 1.909; Q2/ORTHOPEDICS)
  94. Dorai H, Vukicevic S, Sampath K. Bone Morphogenetic Protein-7 (Osteogenic Protein-1) inhibits smooth muscle cell (SMC) proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. Journal of Cellular Physiology 184:37-45, 2000. (IF 4.586; Q1/PHYSIOLOGY)
  95. Jelic M, Pecina M, Haspl M, Kos J, Taylor K, Maticic D, McCartney J, Yin S, Rueger D, Vukicevic S. Regeneration of articular cartilage chondral defects by osteogenic protein-1 (bone morphogenetic protein-7) in sheep. Growth Factors 19:101-113, 2001. (IF 2.468; Q3/CELL BIOLOGY)
  96. Pecina M, Giltaj LR, Vukicevic S. Orthopaedic applications of osteogenic protein-1 (BMP-7). International Orthopedics (SICOT) 25:203-208, 2001. (IF 1.825; Q2/ORTHOPEDICS)
  97. Paralkar VM, Grasser WA, Vail AL, Baumann AP, Owen TA, Smock SL, Martinovic S, Borovecki F, Vukicevic S, Ke HZ, Thompson DD. Regulation of BMP-7 expression by retinoic acid and prostaglandin E2. Journal of Cellular Physiology 190:207-217, 2002. (IF 4.845; Q1/CELL BIOLOGY)
  98. Borovecki F, Basic N, Jelic M, Rogic D, Dorai H, Stavljenic-Rukavina A, Sampath TK, Vukicevic S. The role of bone morphogenetic proteins in kidney development and repair. In: Bone Morphogenetic Proteins: From Laboratory to Clinical Practice (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin pp 263-288, 2002.
  99. Martinovic S, Borovecki F, Sampath TK, Vukicevic S. Biology of bone morphogenetic proteins. In: Bone Morphogenetic Proteins: From Laboratory to Clinical Practice (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 87-119, 2002.
  100. Jelic M, Pecina M, Haspl M, Brkic A, Vukicevic S. BMPs in articular cartilage repair. In: Bone Morphogenetic Proteins: From Laboratory to Clinical Practice (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 249-262, 2002.
  101. Paralkar VM, Grasser W, Baumann A, Castleberry T, Owen T, Vukicevic S. Prostate-derived factor and growth and differentiation factor-8: Newly discovered members of the TGF-beta superfamily. In: Bone Morphogenetic Proteins: From Laboratory to Clinical Practice (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 19-30, 2002.
  102. Pecina M, Jelic M, Martinovic S, Haspl M, Vukicevic S. Articular cartilage repair: the role of bone morphogenetic proteins. International Orthopaedics (SICOT) 26:131-136, 2002. (IF 0.353; Q2/ORTHOPEDICS)
  103. Maric I, Poljak Lj, Zoricic S, Bobinac D, Bosukonda D, Sampath TK, Vukicevic S. BMP-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. Journal of Cellular Physiology 196:258-264, 2003. (IF 5.463; Q1/CELL BIOLOGY)
  104. Paralkar V, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, Owen TA, Li M, DaSilva-Jardine P, Zhou M, Dunn RL, Dumont F, Korsmeyer R, Krasney P, Brown TA, Plowchauk D, Vukicevic S, Thompson DD. An EP2 receptor-selective prostaglandin E2 agonist to induce bone healing. Proceeding of the National Academy of Sciences of the USA 100:6736-6740, 2003. (IF 10.27; Q1/MULTIDISCIPLINARY SCIENCES)
  105. Kusec V, Jelic M, Borovecki F, Kos J, Vukicevic S, Korzinek K. Distraction osteogenesis by Ilizarov and unilateral external fixators in dogs-model evaluation. International Orthopedics (SICOT) 27:47-52, 2003. (IF 0.542; Q3/ORTHOPEDICS)
  106. Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. Journal of Anatomy 202:269-277, 2003. (IF 2.072; Q1/ANATOMY & MORPHOLOGY)
  107. Pecina M, Haspl M, Jelic M, Vukicevic S. Repair of a resistant tibial non-union with a recombinant BMP-7. International Orthopedics (SICOT) 27:320-321, 2003. (IF 0.542; Q3/ORTHOPEDICS)
  108. Djapic T, Kusec V, Jelic M, Vukicevic S, Pecina M. Compressed homologous cancellous bone graft with BMP-7 or bone marrow accelerates healing of the long bone critical defect: A study in rabbits. International Orthopedics (SICOT) 27:326-330, 2003. (IF 0.542; Q3/ORTHOPEDICS)
  109. Vukicevic S, Borovecki F. Molecular Biology. in: Textbook on Internal Medicine (Editors Vrhovac et al.). Medicinska Naklada, Zagreb, 2003 (in Croatian)
  110. Borovecki F, Jelic M, Grgurevic L, Sampath TK, Bosukonda D, Vukicevic S. Bone morphogenetic proteins-7 from serum of pregnant mice is available to the fetus through placental transfer during early stages of development. Nephron-Experimental Nephrology 97:26-32, 2004. (IF 0.950; Q3/UROLOGY & NEPHROLOGY)
  111. Mihelic R, Pecina M, Jelic M, Zoricic S, Kusec V, Simic P, Bobinac D, Lah B, Legovic D, Vukicevic S. BMP-7 (OP-1) promotes tendon graft integration in anterior cruciate ligament reconstruction in sheep. American Journal of Sports Medicine 32:1619-1625, 2004. (IF 2.402; Q1/SPORT SCIENCES)
  112. Martinovic S, Mazic S, Kisic V, Basic N, Jakic-Razumovic J, Borovecki F, Batinic D, Grgurevic L, Simic P, Labar B, Vukicevic S. Expression of bone morphogenetic proteins in stromal cells from human bone marrow long-term culture. Journal of Histochemistry and Cytochemistry 52:1159-67, 2004. (IF 2.513; Q2/CELL BIOLOGY
  113. Paralkar VM, Grasser WA, Riccardi KA, Thompson DD, Vukicevic S. Bone Healing: Bone Morphogenetic Proteins and beyond. In: Bone Morphogenetic Proteins: Regeneration of Bone and Beyond (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 293-304, 2004.
  114. Martinovic S, Simic P, Borovecki F, Vukicevic S. Biology of Bone Morphogenetic Proteins. In: Bone Morphogenetic Proteins: Regeneration of Bone and Beyond (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 45-72, 2004.
  115. Simic P, Vukicevic S. BMPs in development. In: Bone Morphogenetic Proteins: Regeneration of Bone and Beyond (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 73-108, 2004.
  116. Borovecki F, Simic P, Grgurevic L, Vukicevic S. BMPs in regeneration of kidney. In: Bone Morphogenetic Proteins: Regeneration of Bone and Beyond (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 213-244, 2004.
  117. Simic P, Vukicevic S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine and Growth Factor Reviews 16:299-308, 2005. (IF 9.075; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  118. Bilic R, Simic P, Jelic M, Stern-Padovan R, Dodig D, Pompe H, Martinovic S, Ivankovic D, Pecina M, Vukicevic S. Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis. International Orthopaedics 30:128-34, 2006. (IF 0.977; Q3/ORTHOPEDICS)
  119. Martinovic S, Borovecki F, Miljavac V, Kisic V, Maticic D, Francetic I, Vukicevic S. Requirement of a bone morphogenetic protein for the maintenance and stimulation of osteoblast differentiation. Archives of Histology and Cytology 1:23-36, 2006. (IF 1.392; Q4/CELL BIOLOGY)
  120. Anticevic D, Jelic M, Vukicevic S. Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report. Journal of Pediatric Orthopaedics B 15:220-1, 2006. (IF 0.534; Q3/ORTHOPEDICS)
  121. Simic P, Buljan Culej J, Orlic I, Grgurevic L, Draca N, Spaventi R, Vukicevic S. Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption. Journal of Biological Chemistry 281:25509-21, 2006. (IF 5.808; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  122. Vukicevic S, Simic P, Borovecki F, Grgurevic L, Orlic I, Grasser W, Thompson DD, Paralkar V. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E-2 in acute and chronic kidney failure. Kidney International 70:1099-106, 2006. (IF 4.773; Q1/UROLOGY & NEPHROLOGY)
  123. Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O’brien S, Schiavi SC, McPherson JM, Vukicevic S. Thyroid stimulating hormone restores bone volume, microarchitecture and strength in aged ovariectomized rats. Journal of Bone and Mineral Research 22:849-59, 2007. (IF 6.004; Q1/ENDOCRINOLOGY & METABOLISM)
  124. Simic P and Vukicevic S. Bone morphogenetic proteins: From developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Reports 8:327-31, 2007. (IF 7.450; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  125. Smoljanovic T, Vukicevic S, Pecina M. Bone morphogenetic protein and fusion. Journal of Neurosurgery. Spine 6:378-9, 2007. (IF 1.686; Q2/SURGERY)
  126. Orlic I, Borovecki F, Simic P, Vukicevic S. Gene expression profiling in bone tissue of osteoporotic mice. Archives of Industrial Hygiene and Toxicology 58:3-11, 2007.
  127. Simic P, Giljevic Z, Simunic V, Vukicevic S, Korsic M. [Treatment of osteoporosis]. Archives of Industrial Hygiene and Toxicology 58:55-71, 2007.
  128. Bernardo ME, Emons JA, Karperien M, Nauta AJ, Willemze R, Roelofs H, Romeo S, Marchini A, Rappold GA, Vukicevic S, Locatelli F, Fibbe WE. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connective Tissue Research 48:132-40, 2007. (IF 1.085; Q2/ORTHOPEDICS)
  129. Grgurevic L, Macek B, Erjavec I, Oppermann H, Mann M, Vukicevic S. Urine release of systemically administered bone morphogenetic protein hybrid molecule. Journal of Nephrology 20:311-319, 2007. (IF 1.138; Q3/UROLOGY & NEPHROLOGY)
  130. Pecina M, Vukicevic S. Biological aspects of bone, cartilage and tendon regeneration (editorial). International Orthopaedics 31:719-720, 2007. (IF 0.903; Q2/ORTHOPEDICS)
  131. Borovecki F, Pecina-Slaus N, Vukicevic S. Biological mechanisms of bone and cartilage remodeling – Genomic perspective. International Orthopaedics 31:799-805, 2007. (IF 0.903; Q2/ORTHOPEDICS)
  132. Grasser WA, Orlic I, Borovecki F, Riccardi KA, Simic P, Vukicevic S, Paralkar VM. BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. International Orthopaedics 31:759-765, 2007. (IF 0.903; Q2/ORTHOPEDICS)
  133. Grgurevic L, Macek B, Durdevic D, Vukicevic S. Detection of bone and cartilage-related proteins in plasma of patients with a bone fracture using liquid chromatography-mass spectrometry. International Orthopaedics 31:743-751, 2007. (IF 0.903; Q2/ORTHOPEDICS)
  134. Pecina M, Vukicevic S (Ed.). Biological regeneration of bone, cartilage and tendon [special issue]. International Orthopaedics 31(6), 2007. (IF 0.903; Q2/ORTHOPEDICS)
  135. Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R, Henriquez NV, ten Dijke P, Borovecki F, Markwalder R, Thalmann GN, Papapoulos SE, Pelger RC, Vukicevic S, Cecchini MG, Lowik CW, van der Pluijm G. BMP7, a Putative Regulator of Epithelial Homeostasis in the Human Prostate, Is a Potent Inhibitor of Prostate Cancer Bone Metastasis In Vivo. American Journal of Pathology 171:1047-57, 2007. (IF 5.487; Q1/PATHOLOGY)
  136. Buijs J, Henriquez NV, van Overveld PGM, van der Horst G, Que I, Schwaninger R, Rentsch C, ten Dijke P, Cleton-Jansen AM, Notting IC, Vukicevic S, Lidereau R, Papapoulos SE, Cecchini MG, Löwik CWGM, van der Pluijm G. Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer. Cancer Research 67:8742-51, 2007. (IF 7.672; Q1/ONCOLOGY)
  137. Notting I, Buijs J, Mintardjo R, van der Horst G, Vukicevic S, Lowik C, Schalij-Delfos N, Keunen J, van der Pluijm G. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo. Investigative Ophthalmology and Visual Science 48:4882-9, 2007. (IF 3.528; Q1/OPHTHALMOLOGY)
  138. Smoljanovic T, Grgurevic L, Jelic M, Vukicevic S, Pecina M. Regeneration of the skeleton by recombinant human bone morphogenetic proteins. Collegium Antropologicum 31:923-932, 2007. (IF 0.614)
  139. Vukicevic S, Jelic M, Haspl M. Uzgoj i primjena hrskavicnih stanica [Cultivation and implantation of chondrocytes]. Acta Medica Croatica 61:453-457, 2007.
  140. Sun L, Vukicevic S, Baliram R, Yang G, Sendak R, McPherson J, Zhu LL, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah K, Moonga BS, Gabet Y, Davies TF, Bab I, Abe E, Sampath K, Zaidi M. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proceedings of the National Academy of Sciences of the USA 105:4289-4294, 2008. (IF 9.380; Q1/MULTIDISCIPLINARY SCIENCES)
  141. Vukicevic S, Sampath TK (editors). Bone Morphogenetic Proteins: From Local to Systemic Therapeutics. PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, 2008.
  142. Vukicevic S, Simic P, Grgurevic L, Borovecki F, Sampath K. Systemic administration of bone morphogenetic proteins. In: Bone Morphogenetic Proteins: From Local to Systemic Therapeutics (Editors: Vukicevic S, Sampath TK), PIR Series, Birkauser Verlag AG, Basel, Boston, Berlin, pp 317-337, 2008.
  143. Sampath TK, Simic P, Moreno S, Bukanov N, Draca N, Kufner V, Tikvica A, Blair A, Semenski D, Brncic M, Burke SK, Vukicevic S. Sevelamer Restores Bone Volume and Improves Bone Microarchitecture and Strength in Aged Ovariectomized Rats. Endocrinology 149:6092-6102, 2008. (IF 4.945; Q1/ENDOCRINOLOGY & METABOLISM)
  144. Silverman SL, Christiansen C, Genant HK, Vukicevic S, Zanchetta JR, de Villiers TJ, Constantine GD, Chines AA. Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo- and Active-Controlled Clinical Trial. Journal of Bone and Mineral Research 23:1923-1934, 2008. (IF 6.443; Q1/ENDOCRINOLOGY & METABOLISM)
  145. Maric I, Kucic N, Grahovac B, Bobinac D, Vukicevic S. [Expression of bone morphogenetic protein-2 and -7 during experimental inflammatory bowel disease] Izrazaj kostanog morfogenetskog proteina-2 i -7 tijekom eksperimentalne upalne bolesti crijeva. Medicina 44:60-66, 2008.
  146. Andriopoulos Jr B, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, Babitt JL. BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism. Nature Genetics 41:482-487, 2009. (IF 34.284; Q1/GENETICS & HEREDITY)
  147. Vukicevic S, Grgurevic L. BMP-6 and mesenchymal stem cell differentiation. Cytokine and Growth Factor Reviews 20:441-8, 2009. (IF 6.489; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  148. Raggi P, Vukicevic S, Moysés RM, Wesseling K, Spiegel DM. Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders. Clinical Journal of the American Society of Nephrology 5:S31 – S40, 2010. (IF 4.763; Q1/UROLOGY & NEPHROLOGY)
  149. Song K, Krause C, Shi S, Patterson M, Sutto R, Grgurevic L, Vukicevic S, van Dinther M, Falb D, ten Dijke P, Alaoui-Ismaili MH. Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior-agonist activity. Journal of Biological Chemistry 285:12169-80, 2010. (IF 5.328; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  150. Cummings SR, Ensrud K, Delmas PD, LaCroix A, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Zanchetta J, Kendler D, Neven P, Eastell R. Lasofoxifene in Postmenopausal Women with Osteoporosis. New England Journal of Medicine 362:686-96, 2010. (IF 53.486; Q1/MEDICINE, GENERAL & INTERNAL)
  151. Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R. Lasofoxifene in postmenopausal women with osteoporosis. Obstetrical and Gynecological Survey 65:447-8, 2010. (IF 2.167; Q1/OBSTETRICS & GYNECOLOGY)
  152. Corradini E, Schmidt PJ, Meynard D, Garuti C, Montosi G, Chen S, Vukicevic S, Pietrangelo A, Lin HY, Babitt JL. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. Gastroenterology 139:1721-9, 2010. (IF 12.032; Q1/GASTROENTEROLOGY & HEPATOLOGY)
  153. Idris A, Krishnan M, Simic P, Landao-Bassonga E, Mollat P, Vukicevic S, Ralston SH. Small molecule inhibitors of IKK signalling inhibit osteoclast formation in vitro and ovariectomy induced bone loss in vivo. FASEB Journal 24:4545-55, 2010. (IF 6.515; Q1/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  154. Ensrud KE, LaCroix AZ, Thompson JR, Thompson DD, Eastell R, Reid DM, Vukicevic S, Cauley J, Barrett-Connor E, Armstrong R, Welty F, Cummings S. Lasofoxifene and Cardiovascular Events in Postmenopausal Women with Osteoporosis: Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial. Circulation 122:1716-24, 2010. (IF 14.432; Q1/CARDIAC & CARDIOVASCULAR SYSTEMS)
  155. LaCroix AZ, Powles T, Osborne CK, Wolter K, Thompson JR, Thompson DD, Allred DC, Armstrong R, Cummings SR, Eastell R, Ensrud KE, Goss P, Lee A, Neven P, Reid DM, Curto M, Vukicevic S; PEARL Investigators. Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. Journal of the National Cancer Institute 102:1706-15, 2010. (IF 14.697; Q1/ONCOLOGY)
  156. Grgurevic L, Macek B, Healy DR, Brault AL, Erjavec I, Cipcic A, Grgurevic I, Rogic D, Galesic K, Brkljacic J, Stern-Padovan R, Paralkar VM, Vukicevic S. Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis. Journal of the American Society of Nephrology 22:681-9, 2011. (IF 9.663; Q1/UROLOGY & NEPHROLOGY)
  157. Klose A, Waerzeggers Y, Monfared P, Vukicevic S, Kaijzel EL, Winkeler A, Wickenhauser C, Löwik CW, Jacobs AH. Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. Neoplasia 13:276-85, 2011. (IF 5.946; Q1/ONCOLOGY)
  158. Grgurevic L, Macek B, Mercep M, Jelic M, Smoljanovic T, Erjavec I, Dumic-Cule I, Prgomet S, Durdevic D, Vnuk D, Lipar M, Stejskal M, Kufner V, Brkljacic J, Maticic D, Vukicevic S. Bone morphogenetic protein (BMP)1-3 enhances bone repair. Biochemical and Biophysical Research Communications 408:25-31, 2011. (IF 2.484; Q3/BIOCHEMISTRY & MOLECULAR BIOLOGY)
  159. Meynard D, Vaja V, Sun CC, Corradini E, Chen S, Lopez-Otin C, Grgurevic L, Hong CC, Stirnberg M, Guetschow M, Vukicevic S, Babitt JL, Lin HY. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood 118:747-56, 2011. (IF 9.898; Q1/HEMATOLOGY)
  160. Draca N, Tikvica A, Eljuga D, Semenski D, Brncić M, Vukicevic S. Biomechanical properties of bones from rats treated with sevelamer. Collegium Antropologicum 35:557-63, 2011. (IF 0.61)
  161. Vukicevic S, Grgurevic L. The PEARL Trial: Lasofoxifene and incidence of fractures, breast cancer, and cardiovascular events in Postmenopausal Osteoporotic Women. International Journal of Clinical Rheumatology 6:387-91, 2011.
  162. Razdorov G, Vukicevic S. The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples. pp. 259-284, 2011. In: Applications of Tandem Mass Spectrometry. Editor: Dr. Jeevan Prasain, InTech. ISBN 978-953-307-870-0
  163. Bozic D, Grgurevic L, Erjavec I, Brkljacic J, Orlic I, Razdorov G, Grgurevic I, Vukicevic S, Plancak D. The proteome and gene expression profile of cementoblastic cells treated by bone morphogenetic protein-7 in vitro. Journal of Clinical Periodontology 39:80-90, 2012. (IF 3.688; Q1/DENTISTRY, ORAL SURGERY & MEDICINE)
  164. Eastell R, Reid DM, Vukicevic S, Ensrud KE, LaCroix AZ, Thompson JR, Thompson DD, Cummings SR. Effects of 3 Years of Lasofoxifene Treatment on Bone Turnover Markers in Women With Postmenopausal Osteoporosis. Bone 50:1135-40, 2012. (IF 3.823; Q1/ENDOCRINOLOGY & METABOLISM)
  165. Maric I, Kucic N, Turk T, Smoljan I, Grahovac B, Zoricic Cvek S, Celic T, Bobinac D, Vukicevic S. BMP signaling pathway in the rat model of TNBS colitis following BMP7 therapy. American Journal of Physiology – Gastrointestinal and Liver Physiology 302:G1151-62, 2012. (IF 3.649; Q1/GASTROENTEROLOGY & HEPATOLOGY)
  166. Razdorov G, Vukicevic S. The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples. / In: Tandem Mass Spectrometry – Applications and Principles, Dr Jeevan Prasain (Ed.), InTech doi: 10.5772/33358.
  167. Brkljacic J, Pauk M, Erjavec I, Cipcic A, Grgurevic L, Zadro R, Inman GJ, Vukicevic S. Exogenous heparin binds and inhibits bone morphogenetic protein 6 (BMP6) biological activity. International Orthopaedics 37:529-41, 2013. (IF 2.019; Q1/ORTHOPEDICS)
  168. Grazio S, Razdorov G, Erjavec I, Grubisic F, Kusic Z, Punda M, Anticevic D, Vukicevic S, Grgurevic L. Differential expression of proteins with heparin affinity in patients with rheumatoid and psoriatic arthritis– a preliminary study. Clinical and Experimental Rheumatology 31:665-71, 2013. (IF 2.973; Q2/RHEUMATOLOGY)
  169. Boon MR, van den Berg SAA, Wang Y, Van den Bossche J, Karkampouna S, Bauwens M, De Saint-Hubert M, van der Horst G, Vukicevic S, de Winther MPJ, Havekes LM, Jukema W, Tamsma JT, van der Pluijm G, Willems van Dijk K, Rensen PCN. BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutrality. PLOS One 8:e74083, 2013. (IF 3.534; Q1/MULTIDISCIPLINARY SCIENCES)
  170. Vukicevic S, Oppermann H, Verbanac D, Jankolija M, Popek I, Curak J, Brkljacic J, Pauk M, Erjavec I, Francetic I, Dumic-Cule I, Jelic M, Durdevic D, Vlahovic T, Novak R, Kufner V, Bordukalo Niksic T, Kozlovic M, Banic Tomisic Z, Bubic-Spoljar J, Bastalic I, Vikic-Topic S, Peric M, Pecina M, Grgurevic L. The clinical use of bone morphogenetic proteins (BMPs) revisited: A novel BMP6 biocompatible carrier device OSTEOGROW for bone healing. International Orthopaedics, 37:529-41, 2014. (IF 2.019; Q1/ORTHOPEDICS)
  171. Dumic-Cule I, Draca N, Tikvica Luetic A, Jezek D, Rogic D, Grgurevic L, Vukicevic S. TSH prevents bone resorption and with calcitriol synergistically stimulates bone formation in rats with low levels of calciotropic hormones. Hormone and Metabolic Research, 46:305-312, 2014. (IF 2.038; Q3/ENDOCRINOLOGY & METABOLISM)
  172. Pecina M, Vukicevic S. Tissue engineering and regenerative orthopaedics (TERO). International Orthopaedics 38:1757-60, 2014. (IF 2.019; Q1/ORTHOPEDICS)
  173. Pecina M, Vukicevic S (editors). Tissue engineering and regenerative orthopaedics (TERO) [special issue]. International Orthopaedics 38(9), 2014. (IF 2.110; Q2 in ORTHOPEDICS)
  174. Dumic-Cule I, Brkljacic J, Rogic D, Bordukalo Niksic T, Tikvica Luetic A, Draca N, Kufner V, Trkulja V, Grgurevic L, Vukicevic S. The rational use of animal models in the evaluation of novel bone regenerative therapies. International Orthopaedics, 38:1979-85, 2014. (IF 2.019; Q1/ORTHOPEDICS)
  175. Vukicevic S, Grgurevic L. Bone morphogenetic proteins in inflammation. In: Parnham M. (eds) Encyclopedia of Inflammatory Diseases. Birkhauser, Basel. 2014.
  176. Cvjeticanin B, Prutki M, Dumic-Cule I, Veir Z, Grgurevic L, Vukicevic S. Possible target for preventing fibrotic scar formation following acute myocardial infarction. Med Hypotheses 83:656-8, 2014
  177. Jelic M, Grgurevic L, Vukicevic S. Scaffold-free Endogenous Healing of the Articular Cartilage Lesion. In: Sports Injuries, Springer Verlag, 2014.
  178. Peric M, Dumic-Cule I, Grcevic D, Matijasic M, Verbanac D, Grgurevic L, Trkulja V, Bagi CM, Vukicevic S. The rational use of animal models in the evaluation of novel bone regenerative therapies. Bone 70:73-86, 2015.  (IF 4.461; Q1/ENDOCRINOLOGY & METABOLISM)
  179. Pauk M, Grgurevic L, Brkljacic J, Kufner V, Bordukalo-Niksic T, Grabusic K, Razdorov G, Rogic D, Zuvic M, Oppermann H, Babitt J, Lin H, Volarevic S, Vukicevic S. Exogenous BMP7 corrects the plasma iron overload and bone loss in Bmp6-/- mice. International Orthopaedics 39:161-72, 2015. (IF 2.019; Q1/ORTHOPEDICS)
  180. Dumic-Cule I, Pecina M, Jelic M, Jankolija M, Popek I, Grgurevic L, Vukicevic S. Biological aspects of segmental bone defects management. International Orthopaedics 39:1005-11, 2015. (IF 2.387; Q2 in ORTHOPEDICS)
  181. Vojta L, Ljuma Skupnjak L, Budimir A, Vukicevic S, Fulgosi H. Rapid transient expression of human granulocyte-macrophage colony-stimulating factor in two industrial cultivars of tobacco (Nicotiana tabacum) by agroinfiltration. Biotechnology Reports 7:81-86, 2015.
  182. Jurisic D, Erjavec I, Trkulja V, Dumic-Cule I, Hadzibegovic I, Kovacevic L, Svagusa T, Stanec Z, Vukicevic S, Grgurevic L. Soluble type III TGFβ receptor in diagnosis and follow-up of patients with breast cancer. Growth Factors 33:200-9, 2015. (IF 2.043; Q3 in ENDOCRINOLOGY & METABOLISM)
  183. Blazevic S, Erjavec I, Brizic M, Vukicevic S, Hranilovic D. Molecular background and physiological consequences of altered peripheral serotonin homeostasis in adult rats perinatally treated with tranylcypromine. Journal of Physiology and Pharmacology 66:529-37, 2015 (IF 3.222; Q2 in PHYSIOLOGY)
  184. Vukicevic S, Grgurevic L. Bone morphogenetic proteins in inflammation. In: Parnham M.J. (eds) Compendium of Inflammatory Diseases. Springer Verlag, Basel. pp 229-242, 2016.
  185. Štoković N, Trkulja V, Dumić-Čule I, Čuković-Bagić I, Lauc T, Vukičević S, Grgurević L. Sphenoid sinus types, dimensions and relationship with surrounding structures. Annals of Anatomy 203:69-76, 2016. doi: 10.1016/j.aanat.2015.02.013 (IF 1.308; Q2 in ANATOMY & MORPHOLOGY)
  186. Grgurevic L, Christensen GL, Schulz TJ, Vukicevic S. Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism. Cytokine and Growth Factor Reviews 27:105-1810, 2016. (IF 5.357; Q1 in BIOCHEMISTRY AND MOLECULAR BIOLOGY and Q1 in CELL BIOLOGY)
  187. Benn A, Bredow C, Casanova I, Vukicevic S, Knaus P. VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling. Journal of Cell Science 129:206-18, 2016. doi: 10.1242/jcs. 179960 (IF 4.431; Q2 in CELL BIOLOGY)
  188. Erjavec I, Bordukalo-Niksic T, Brkljacic J, Grcevic D, Mokrovic G, Kesic M, Rogic D, Zavadoski W, Paralkar V, Grgurevic L, Trkulja V, Cicin-Sain L, Vukicevic S. Constitutively elevated blood serotonin is associated with bone loss and type 2 diabetes in rats. PLoS One 11:e0150102, 2016. doi: 10.1371/journal.pone.0150102 (IF 3.057; Q1 in MULTIDISCIPLINARY SCIENCES)
  189. Vukicevic S. Challenges and Hurdles in New Drug Development. Clinical Therapy 38(10S):e3, 2016. doi: 10.1016/j.clinthera.2016.07.019
  190. Grgurević L, Dumić-Čule I, Vukičević S. OSTEOGROW – nova terapija za koštanu regeneraciju. Fizikalna i rehabilitacijska medicina 28:102-110, 2016.
  191. Erjavec I, Brkljacic J, Vukicevic S, Jakopovic B, Jakopovich I. Mushroom Extracts Decrease Bone Resorption and Improve Bone Formation. International Journal of Medicinal Mushrooms 18:559-69, 2016. (IF 1.272; Q4 in PHARMACOLOGY AND PHARMACY)
  192. Vukicevic S, Sampath TK (editors). Bone Morphogenetic Proteins: Systems Biology Regulators. PIR Series, Springer International Publishing 2017.
  193. Grgurevic L, Erjavec I, Dumic-Cule I, Bordukalo-Niksic T, Pauk M, Trkulja V, Maticic D, Pecin M, Lipar M, Peric M, Vukicevic S. Osteogrow: A novel bone graft substitute for orthopedic reconstruction. In: Vukicevic S, Sampath TK (editors). Bone Morphogenetic Proteins: Systems Biology Regulators. PIR Series, Springer International Publishing pp. 215-228, 2017.
  194. Sampath TK, Grgurevic L, Vukicevic S. Bone morphogenetic protein-7 and its role in acute kidney injury and chronic kidney failure. In: Vukicevic S, Sampath TK (editors). Bone Morphogenetic Proteins: Systems Biology Regulators. PIR Series, Springer International Publishing pp. 271-291, 2017.
  195. Grgurevic L, Dumic-Cule I, Vukicevic S. BMPs in inflammation. In: Vukicevic S, Sampath TK (editors). Bone Morphogenetic Proteins: Systems Biology Regulators. PIR Series, Springer International Publishing pp. 357-366, 2017.
  196. Grgurevic L, Pecina M, Vukicevic S. Marshall R. Urist and the discovery of bone morphogenetic proteins. International Orthopaedics 41:1065-1069, 2017. doi: 10.1007/s00264-017-3402-9 (IF 2.520; Q1 in ORTHOPEDICS)
  197. Vukicevic S, Grgurevic L, Pecina M. Clinical need for bone morphogenetic proteins. International Orthopedics 41:2415-2416, 2017. doi: 10.1007/s00264-017-3550-y (IF 2.520; Q1 in ORTHOPEDICS)
  198. Grgurevic L, Erjavec I, Grgurevic I, Dumic-Cule I, Brkljacic J, Verbanac D, Matijasic M, Cipcic Paljetak H, Novak R, Plecko M, Bubic J, Rogic D, Kufner V, Pauk M, Bordukalo Niksic T, Vukicevic S. Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats. Growth Factors 35:201-215, 2017. doi: 10.1080/08977194.2018.1428966 (IF 1.800; Q4 in CELL BIOLOGY)
  199. Vukičević S, Kusić Z, Grgurević L. Science communication to the public. Croatian Medical Journal 59:43-45, 2018. (IF 1.624; Q2 in MEDICINE GENERAL & INTERNAL)
  200. Dumic-Cule I, Peric M, Kucko L, Grgurevic L, Pecina M, Vukicevic S. Bone morphogenetic proteins in fracture repair. International Orthopaedics 42:2619-2626, 2018. doi: 10.1007/s00264-018-4153-y (IF 2.384; Q2 in ORTHOPEDICS)
  201. Grgurevic L, Vukicevic S. OSTEOGROW – novel bone device for bone regeneration. Rad Croatian Academy of Sciences and Arts. Medical Sciences 533(45): 71-80, 2018.
  202. Eddowes LA, Al-Hourani K, Ramamurthy N, Frankish J, Baddock HT, Sandor C, Ryan JD, Fusco DN, Arezes J, Giannoulatou E, Boninsegna S, Chevaliez S, Owens BMJ, Chi Sun C, Fabris P, Giordani MT, Martines D, Vukicevic S, Crowe J, Lin HY, Rehwinkel J, McHugh PJ, Binder M, Babbit JL, Chung RT, Lawless MW, Armitage AE, Webber C, Klenerman P, Drakesmith H. Antiviral activity of bone morphogenetic proteins and activins. Nature Microbiology 4:339-351, 2019. doi: 10.1038/s41564-018-0301-9 (IF 14.174; Q1 in MICROBIOLOGY)
  203. Pauk M, Bordukalo-Niksic T, Brkljacic J, Paralkar V, Brault AL, Dumic-Cule I, Borovecki F, Grgurevic L, Vukicevic S. A novel role of bone morphogenetic protein-6 (BMP-6) in glucose homeostasis. Acta Diabetologica 56:365-371, 2019. doi: 10.1007/s00592-018-1265-1 (IF 3.418; Q2 in ENDOCRINOLOGY & METABOLISM)
  204. Grgurevic L, Pecin M, Erjavec I, Capag H, Pauk M, Kufner V, Lipar M, Bubic Spoljar J, Bordukalo-Niksic T, Maticic D, Oppermann H, Peric M, Sampath TK, Vukicevic S. Recombinant human bone morphogenetic protein 6 delivered within autologous blood coagulum restores critical size segmental defects of ulna in rabbits. Journal of Bone and Mineral Research Plus 3:e10085, 2019. doi: 10.1002/jbm4.10085
  205. Suton P, Bolanca A, Grgurevic L, Erjavec I, Nikles I, Muller D, Manojlovic S, Vukicevic S, Petrovecki M, Dokuzovic S, Luksic I. Prognostic significance of bone morphogenetic protein 6 (BMP6) expression, clinical and pathological factors in clinically node-negative oral squamous cell carcinoma (OSCC). Journal of Craniomaxillofacial Surgery 47:80-86, 2019. (IF 1.766; Q3 in SURGERY)
  206. Vukicevic S, Stokovic N, Pecina M. Is ceramics an appropriate bone morphogenetic protein delivery system for clinical use? International Orthopaedics 43:1275-1276, 2019. doi: 10.1007/s00264-019-04322-0 (IF 2.854; Q1 in ORTHOPEDICS)
  207. LaCroix A, Šimunić V, Vukičević S. Unopposed estrogen and endometrial cancer: association or causation? Croatian Medical Journal 60:389, 2019. (IF 1.247; Q3 in MEDICINE GENERAL & INTERNAL)
  208. Nemecek E, Chiari C, Valentinitsch A, Kainberger F, Hobusch G, Kolb A, Hirtler L, C Trost, Vukicevic S, Windhager R. Analysis and quantification of bone healing after open wedge high tibial osteotomy. Wiener klinische Wochenschrift 131:627-629, 2019. doi: 10.1007/s00508-019-01541-8 (IF 1.323; Q3 in MEDICINE GENERAL & INTERNAL)
  209. Nemecek E, Chiari C, Valentinitsch A, Kainberger F, Hobusch G, Kolb A, Hirtler L, Trost C, Vukicevic S, Windhager R. Correction to: Analysis and quantification of bone healing after open wedge high tibial osteotomy. Wiener klinische Wochenschrift 131:627-629, 2019. doi: 10.1007/s00508-019-01568-x (IF 1.323; Q3 in MEDICINE GENERAL & INTERNAL)
  210. Posa F, Grab AL, Martin V, Hose D, Seckinger A, Mori G, Vukicevic S, Cavalcanti-Adam EA. Copresentation of BMP-6 and RGD ligands enhances cell adhesion and BMP-mediated signaling. Cells 8:1646, 2019 (IF 5.656) (IF 4.366; Q2 in CELL BIOLOGY)
  211. Vukicevic S, Grgurevic L, Erjavec I, Pecin M, Bordukalo-Niksic T, Stokovic N, Lipar M, Capak H, Maticic D, Windhager R, Sampath KT, Gupta M. Autologous Blood Coagulum is a physiological carrier for BMP6 to induce new bone formation and promote posterolateral lumbar spine fusion in rabbits. Journal of Tissue Engineering and Regenerative Medicine 14:147-159, 2020. doi: 10.1002/term.2981 (IF 3.078; Q2 in BIOTECHNOLOGY & APPLIED MICROBIOLOGY)
  212. Chiari C, Grgurevic L, Bordukalo-Niksic T, Oppermann H, Valentinich A, Nemecek E, Staats K, Schreiner M, Trost C, Kolb A, Kainberger F, Pehar S, Milosevic M, Martinovic S, Peric M, Sampath TK, Vukicevic S, Windhager R. Recombinant human BMP6 applied within Autologous Blood Coagulum accelerates bone healing: Randomized controlled trial in High Tibial Osteotomy patients. Journal of Bone and Mineral Research 2020. doi: 10.1002/jbmr.4107 (IF 5.854; Q1 in ENDOCRINOLOGY & METABOLISM)
  213. Vukicevic S, Sampath TK (editors). The role of bone morphogenetic proteins in musculoskeletal system biology [special issue]. Bone 2020. (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)
  214. Grgurevic L, Erjavec I, Gupta M, Pecin M, Bordukalo-Niksic T, Stokovic N, Vnuk D, Farkas V, Capak H, Milosevic M, Bubic Spoljar J, Peric, M, Vuckovic M, Maticic D, Windhager R, Oppermann H, Sampath TK, Vukicevic S. Autologous blood coagulum containing rhBMP6 induces new bone formation to promote anterior lumbar interbody fusion (ALIF) and posterolateral lumbar fusion (PLF) of spine in sheep. Bone 138: 115448, 2020. doi: 10.1016/j.bone.2020.115448 (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)
  215. Durdevic D, Vlahovic T, Pehar S, Miklic D, Oppermann H, Bordukalo-Niksic T, Gavrankapetanovic I, Jamakosmanovic M, Milosevic M, Martinovic S, Sampath TK, Peric M, Grgurevic L, Vukicevic S. A novel autologous bone graft substitute comprised of rhBMP6 blood coagulum as carrier tested in a randomized and controlled Phase I trial in patients with distal radial fractures. Bone 140:115551, 2020. doi: 10.1016/j.bone.2020.115551 (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)
  216. Stokovic N, Ivanjko N, Pecin M, Erjavec I, Karlovic S, Smajlovic A, Capak H, Milosevic M, Bubic-Spoljar J, Vnuk D, Maticic D, Oppermann H, Sampath TK, Vukicevic S. Evaluation of synthetic ceramics as compression resistant matrix to promote osteogenesis of autologous blood coagulum containing recombinant human bone morphogenetic protein 6 in rabbit posterolateral lumbar fusion model. Bone 140:115544, 2020. doi: 10.1016/j.bone.2020.115544 (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)
  217. Stokovic N, Ivanjko N, Erjavec I, Milosevic M, Oppermann H, Shimp L, Sampath TK, Vukicevic S. Autologous bone graft substitute containing rhBMP6 within autologous blood coagulum and synthetic ceramics of different geometry determines the quantity  and structural pattern of bone formed in a rat subcutaneous model. Bone 2020. doi:  (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)
  218. Sampath TK, Vukicevic S. Biology of Bone Morphogenetic Protein in Bone Repair and Regeneration. Bone 115602, 2020. doi: 10.1016/j.bone.2020.115602 (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)
  219. Lammens J, Maréchal M, Delport H, Geris L, Oppermann H, Vukicevic S, Luyten FP. A cell-based combination product for the repair of large bone defects. Bone 138:115511, 2020. doi: 10.1016/j.bone.2020.115511 (IF 4.147; Q1 in ENDOCRINOLOGY AND METABOLISM)